Report Categories
View AllRecent Articles
View All
What Wheels Up UP does that creates lasting value Trend Strengthens 20260508
Landmark Bancorp LARK Q1 revenue jumps 168 yearoveryear to 706 million shares edge higher
HPEC Hewlett leadership prioritizes AI infrastructure rollouts to drive longterm shareholder value in coming quarters
RGEN Repligen Corporation shares rise 46 percent after Q4 2025 EPS beats consensus estimates by 93 percent
Signos Secures 20M Funding Expands Dexcom Partnership Amid GLP1 Weight Loss Trend
Best Buy Shares Rise as New Product Launches and Higher Tax Refunds Drive Sales
QXO Launches Hostile Takeover Bid for BuildingProducts Rival Beacon
Bengaluru Airport Overtakes Mumbai in April Domestic Passenger Traffic
Wall Street Indexes Edge Higher as Middle East Peace Hopes Buoy Investor Sentiment
Roper Technologies ROP Highlighted Among Inexpensive NASDAQ Stocks in Recent Analysis
LCID Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction
Champions Oncology CSBR Q1 2026 Earnings EPS Misses by Wide Margin as Company Posts Loss
Baidu Q1 2026 Earnings EPS Beats Estimates Amid Mixed Market Sentiment
BAC Q1 2026 Earnings Earnings Beat with 86 Surprise
RDZN Q1 2026 Earnings Significant EPS Miss Amidst Transition
HYPR Q1 2026 Earnings EPS Beat Highlights Cost Discipline Amid Disclosed Revenue Gap
Coeptis Therapeutics COEP Holds Steady at 164 as Key Levels Define Trading Range
Kaixin Holdings KXIN Edges Higher Amid Narrow Trading Range
Quanex Building Products NX Rebounds 3 Approaching Key Resistance Level
Lumexa Imaging Holdings LMRI Slides 22 as Key Support Levels Tested
Nexstar Media Group NXST Holds Steady Near Resistance A Cautious Stance
ProCap Financial Inc Warrant BRRWW Declines 26 as Warrants Trade Near Critical Support Levels
Aurelion Inc AURE Slips 1 Amid Low Volume Testing Support at 236
First Majestic Silver AG Slides Amid Silver Weakness Key Levels in Focus
California BanCorp BCAL Holds Steady with Modest Gain as Stock Nears Resistance
Toro Corp TORO Falls 185 Nears Critical Support at 504
Ernexa Therapeutics Warrants ERNAW Surge 14 as Price Tests Key Resistance Level